BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 209 filers reported holding BEAM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $61 | -25.6% | 2,619 | +5.9% | 0.00% | 0.0% |
| Q1 2024 | $82 | -69.3% | 2,473 | -74.8% | 0.00% | -50.0% |
| Q4 2023 | $267 | +12.7% | 9,818 | -0.2% | 0.00% | 0.0% |
| Q3 2023 | $237 | -24.5% | 9,836 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $314 | +14.6% | 9,836 | +9.9% | 0.00% | +50.0% |
| Q1 2023 | $274 | -33.2% | 8,948 | -14.7% | 0.00% | -50.0% |
| Q4 2022 | $410 | -99.9% | 10,491 | +2.0% | 0.00% | -20.0% |
| Q3 2022 | $490,000 | +26.0% | 10,283 | +2.4% | 0.01% | +25.0% |
| Q2 2022 | $389,000 | -19.0% | 10,040 | +19.8% | 0.00% | 0.0% |
| Q1 2022 | $480,000 | -66.6% | 8,379 | -53.5% | 0.00% | -20.0% |
| Q4 2021 | $1,436,000 | +86.3% | 18,008 | +103.2% | 0.01% | -28.6% |
| Q3 2021 | $771,000 | -32.5% | 8,862 | -0.1% | 0.01% | -22.2% |
| Q2 2021 | $1,142,000 | +151.0% | 8,872 | +56.2% | 0.01% | -47.1% |
| Q1 2021 | $455,000 | -10.1% | 5,680 | -8.4% | 0.02% | -10.5% |
| Q4 2020 | $506,000 | – | 6,204 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,346,934 | $74,937,603 | 45.33% |
| HSG Holding Ltd | 796,089 | $25,419,122 | 2.91% |
| Deep Track Capital, LP | 1,317,316 | $42,061,900 | 1.95% |
| Redmile Group, LLC | 1,485,199 | $47,422,404 | 1.82% |
| ARK Investment Management | 8,382,595 | $267,656,246 | 1.77% |
| Casdin Capital, LLC | 570,000 | $18,200,100 | 1.59% |
| Yiheng Capital Management, L.P. | 463,800 | $14,809,134 | 0.80% |
| Temasek Holdings (Private) Ltd | 4,317,789 | $137,867,003 | 0.80% |
| Alphabet Inc. | 321,604 | $10,268,815 | 0.55% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,441,522 | $109,887,797 | 0.55% |